(For a Reuters live blog on U.S., UK and European stock
markets, click or type LIVE/ in a news window)
*
FTSE 100 up 0.2%, FTSE 250 down 0.3%
*
Defence stocks slip to over 1-week low ahead of
Trump-Putin
meeting
*
UK employers report weaker hiring and pay growth in July
Aug 11 (Reuters) - Britain's blue-chip index climbed on
Monday, led by healthcare and consumer shares, but losses in
defence stocks ahead of this week's renewed Russia-Ukraine peace
negotiations capped gains.
The FTSE 100 was up 0.2% as of 0947 GMT. The FTSE
midcap index was down 0.3%.
The healthcare sector rose 1.1% on Monday.
Drugmaker GSK said the U.S. Food and Drug Administration
will do a priority review of its medicine to treat uncomplicated
gonorrhoea; its shares gained 0.8%. Heavyweight AstraZeneca ( AZN )
was also up 1.5%.
British American Tobacco ( BTI ) and spirits maker Diageo ( DEO )
rose over 1% each.
Retailer Marks & Spencer ( MAKSF ) resumed click-and-collect
orders for clothing after a nearly four-month hiatus following a
cyber hack and data theft, sending its shares 2.4% higher.
On the flip side, a gauge of the aerospace and defence
sector dropped 0.7% to a more than one-week low
as a potential truce in the Russia-Ukraine war nears.
U.S. President Donald Trump will meet Russian President
Vladimir Putin on August 15 in Alaska to negotiate an end to the
war in Ukraine.
Trump said the parties, including Ukraine President
Volodymyr Zelenskiy, were close to a ceasefire deal.
Defence stocks, among the year's best performers, lost 0.8%
last week as the peace efforts gained momentum.
Online trading platform Plus500 fell 2.8% after
weak half-year profit margins and no upgrade to its annual
forecast, making it one of the FTSE 250's top decliners.
The blue-chip FTSE 100 index rose 0.3% last week as
investors weighed strong corporate earnings and a Bank of
England rate decision that signalled the central bank's
rate-cutting cycle may be nearing its end.
On Monday, data showed that hiring intentions by British
businesses fell to their weakest since the COVID-19 pandemic,
and recruiters said starting pay was rising at the slowest pace
in more than four years, adding to signs of a weakening jobs
market.
Looking ahead, U.S. inflation data is due on Tuesday, a key
determinant for the Federal Reserve's interest rate decision
next week.